Ask the Experts: Difficult ERAS Cardiac Surgery Cases

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Vicki Morton-Bailey, DNP, AGNP-BC
Disclosure(s): Edwards Lifesciences: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Nathalie Roy, MD

Presentations

  1. My Patient Has Chronic Pain, Now What?
    Michael C. Grant, MD, MSE
     
  2. Prehabilitation: How Do We Make This Happen?
    Igor Gosev, MD, PhD
     
  3. Oliguria: Are We Shooting from the Hip?
    Daniel T. Engelman, MD
    Disclosure(s): Alexion: Advisory Board (Ongoing); Arthrex: Advisory Board (Ongoing); Astellas Pharmaceuticals: Advisory Board (Ongoing); Edwards Life Science: Advisory Board (Ongoing); Medela: Advisory Board (Ongoing); Renibus Therapeutics: Advisory Board (Ongoing); Terumo: Advisory Board (Ongoing)
     
  4. Hematocrit of 20...You're NOT Going to Transfuse?
    Amanda Rea, DNP, CRNP
    Disclosure(s): Edwards Life Science: Speaker (Ongoing)
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Activity opens: 
02/01/2024
Activity expires: 
02/15/2027
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Vicki Morton-Bailey, DNP, AGNP-BC
Disclosure(s): Edwards Lifesciences: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Nathalie Roy, MD

Presentations

  1. My Patient Has Chronic Pain, Now What?
    Michael C. Grant, MD, MSE
     
  2. Prehabilitation: How Do We Make This Happen?
    Igor Gosev, MD, PhD
     
  3. Oliguria: Are We Shooting from the Hip?
    Daniel T. Engelman, MD
    Disclosure(s): Alexion: Advisory Board (Ongoing); Arthrex: Advisory Board (Ongoing); Astellas Pharmaceuticals: Advisory Board (Ongoing); Edwards Life Science: Advisory Board (Ongoing); Medela: Advisory Board (Ongoing); Renibus Therapeutics: Advisory Board (Ongoing); Terumo: Advisory Board (Ongoing)
     
  4. Hematocrit of 20...You're NOT Going to Transfuse?
    Amanda Rea, DNP, CRNP
    Disclosure(s): Edwards Life Science: Speaker (Ongoing)